These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 33244271)

  • 1. The N6-Methyladenosine (m6A) Methylation Gene 
    Liu T; Yang S; Cheng YP; Kong XL; Du DD; Wang X; Bai YF; Yin LH; Pu YP; Liang GY
    Cancer Manag Res; 2020; 12():11953-11964. PubMed ID: 33244271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YTHDF1 Promotes Proliferation and Inhibits Apoptosis of Gastric Cancer Cells via Upregulating TCF7 mRNA Translation.
    Li Y; Guo X; Liang X; Wang Z
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):117. PubMed ID: 38538279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma.
    Qi LW; Jia JH; Jiang CH; Hu JM
    Front Genet; 2020; 11():614566. PubMed ID: 33519919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor.
    Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N
    Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner.
    Chen H; Yu Y; Yang M; Huang H; Ma S; Hu J; Xi Z; Guo H; Yao G; Yang L; Huang X; Zhang F; Tan G; Wu H; Zheng W; Li L
    Cell Biosci; 2022 Feb; 12(1):19. PubMed ID: 35197112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Validation of the N6-Methyladenosine RNA Methylation Regulator YTHDF1 as a Novel Prognostic Marker and Potential Target for Hepatocellular Carcinoma.
    Bian S; Ni W; Zhu M; Song Q; Zhang J; Ni R; Zheng W
    Front Mol Biosci; 2020; 7():604766. PubMed ID: 33363211
    [No Abstract]   [Full Text] [Related]  

  • 8. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
    Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
    J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YTHDF1's Regulatory Involvement in Breast Cancer Prognosis, Immunity, and the ceRNA Network.
    Luo W; Zhou Y; Wang J; Wang K; Lin Q; Li Y; Xie Y; Li M; Wang J; Xiong L
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets.
    Zhou Y; Yin Z; Hou B; Yu M; Chen R; Jin H; Jian Z
    Cancer Manag Res; 2019; 11():3921-3931. PubMed ID: 31118805
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression profiles and prognostic roles of m6A writers, erasers and readers in gastric cancer.
    Jing JJ; Zhao X; Li H; Sun LP; Yuan Y
    Future Oncol; 2021 Jul; 17(20):2605-2620. PubMed ID: 33878934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The m
    Chen XY; Liang R; Yi YC; Fan HN; Chen M; Zhang J; Zhu JS
    Front Cell Dev Biol; 2021; 9():647702. PubMed ID: 33791305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
    BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and Predictive Value of m6A "Eraser" Related Gene Signature in Gastric Cancer.
    Xu X; Zhou E; Zheng J; Zhang C; Zou Y; Lin J; Yu J
    Front Oncol; 2021; 11():631803. PubMed ID: 33718213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a five m6A-relevant mRNAs signature and risk score for the prognostication of gastric cancer.
    Yin L; Feng S; Sun Y; Jiang Y; Tang C; Sun D
    J Gastrointest Oncol; 2022 Oct; 13(5):2234-2248. PubMed ID: 36388685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The m6A readers
    Anita R; Paramasivam A; Priyadharsini JV; Chitra S
    Am J Cancer Res; 2020; 10(8):2546-2554. PubMed ID: 32905518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic Signature for Esophageal Cancer.
    Xu LC; Pan JX; Pan HD
    Cancer Manag Res; 2020; 12():5385-5394. PubMed ID: 32753956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression Status And Prognostic Value Of M6A-associated Genes in Gastric Cancer.
    Guan K; Liu X; Li J; Ding Y; Li J; Cui G; Cui X; Sun R
    J Cancer; 2020; 11(10):3027-3040. PubMed ID: 32226518
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer.
    Zhang C; Zhang M; Ge S; Huang W; Lin X; Gao J; Gong J; Shen L
    Cancer Med; 2019 Aug; 8(10):4766-4781. PubMed ID: 31243897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ELK1-mediated YTHDF1 drives prostate cancer progression by facilitating the translation of Polo-like kinase 1 in an m6A dependent manner.
    Li P; Shi Y; Gao D; Xu H; Zou Y; Wang Z; Li W
    Int J Biol Sci; 2022; 18(16):6145-6162. PubMed ID: 36439881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.